should third generation egfr inhibitors be used before or after progression?
Published 8 years ago • 36 plays • Length 3:28Download video MP4
Download video MP3
Similar videos
-
5:09
should a third generation egfr inhibitor be first line therapy for egfr mutation-positive nsclc?
-
3:28
are there clinically significant differences among the third generation egfr inhibitors?
-
3:07
third generation egfr tkis for acquired resistance
-
7:48
should avastin be added to egfr tki therapy for egfr mutation-positive nsclc?
-
2:21
should egfr tki therapy be continued beyond progression?
-
8:04
case based panel discussion 3.1 egfr mutation - chemotherapy and an egfr inhibitor concurrently or s
-
26:27
novel egfr inhibitors in the setting of acquired resistance
-
12:58
egfr inhibitor therapy in second line
-
1:17:52
egfr initial treatment, acquired resistance and q&a with h. jack west, md and helena yu, md
-
4:10
3rd generation drug for acquired resistance in egfr lung cancer
-
33:47
gracecast-049_lung-cancer_weiss on egfr therapy for early stage nsclc
-
1:01
dr. philip bonomi: gefitinib and later generations of egfr inhibitors
-
24:36
treatment options for egfr t790m negative acquired resistance
-
52:47
targeted therapies in lung cancer patient forum, aurora, colorado, august 20, 2016
-
11:36
azd9291 for acquired resistance in egfr positive lung cancer
-
8:20
case based panel discussion - egfr - progression, next steps - a place for chemo & immunotherapy? v2
-
2:22
are there distinctions among currently available oral egfr inhibitors?
-
37:41
gracecast-044_lung-cancer_camidge on alk inhibitors
-
3:15
does the specific egfr mutation matter when choosing an oral egfr inhibitor?